Impact of ICER Reports on Hemophilia Treatment Decisions
Russell P. Gollard, MD, FACP, analyzes the role of ICER reports in optimizing patient care and health care costs.
Source: ajmc.com
Stay updated with breaking news from Newer Agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Russell P. Gollard, MD, FACP, analyzes the role of ICER reports in optimizing patient care and health care costs.
Chee Kay Cheung, MBCHB, MRCP, PhD, reviews newly approved agents for the treatment of IgAN, focusing on SGLT2 inhibitors, budesonide, and sparsentan.